{"id":"https://openalex.org/W89369262","doi":null,"title":"Sertraline: a new antidepressant.","display_name":"Sertraline: a new antidepressant.","alternate_titles":[],"publication_year":1988,"publication_date":"1988-08-01","ids":{"openalex":"https://openalex.org/W89369262","mag":"89369262","pmid":"https://pubmed.ncbi.nlm.nih.gov/2842321"},"language":"en","primary_location":{"id":"pmid:2842321","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2842321","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Clinical Trial"},"parent_works":[],"lineage":["https://openalex.org/W89369262"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017215189","display_name":"D.P. Doogan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D P Doogan","raw_affiliation_strings":["Department of Clinical Research, Pfizer Limited, Sandwich, Kent, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Research, Pfizer Limited, Sandwich, Kent, U.K","institution_ids":["https://openalex.org/I189718659"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063053834","display_name":"Vincent Caillard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V Caillard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.3015,"has_fulltext":false,"cited_by_count":160,"citation_normalized_percentile":{"value":0.94226283,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"49 Suppl","issue":null,"first_page":"46","last_page":"51"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sertraline","display_name":"sertraline","score":1.0},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.921999990940094},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.9290000200271606},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.578000009059906},{"id":"https://openalex.org/keywords/depression-recurrence-prevention","display_name":"depression recurrence prevention","score":0.878000020980835},{"id":"https://openalex.org/keywords/beta-adrenergic-receptor-down-regulation","display_name":"beta-adrenergic receptor down-regulation","score":0.9369999766349792},{"id":"https://openalex.org/keywords/platelet-serotonin-uptake","display_name":"platelet serotonin uptake","score":0.9070000052452087},{"id":"https://openalex.org/keywords/plasma-half-life","display_name":"plasma half-life","score":0.8949999809265137},{"id":"https://openalex.org/keywords/psychomotor-function","display_name":"psychomotor performance","score":0.9660000205039978},{"id":"https://openalex.org/keywords/sedation","display_name":"sedation","score":0.8410000205039978},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.6069999933242798},{"id":"https://openalex.org/keywords/xerostomia","display_name":"xerostomia","score":0.5720000267028809},{"id":"https://openalex.org/keywords/nausea","display_name":"nausea","score":0.718999981880188},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.6330000162124634}],"concepts":[{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.9502034783363342},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7306745648384094},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.6763882040977478},{"id":"https://openalex.org/C2780216858","wikidata":"https://www.wikidata.org/wiki/Q58397","display_name":"Amitriptyline","level":2,"score":0.6168084740638733},{"id":"https://openalex.org/C2778689640","wikidata":"https://www.wikidata.org/wiki/Q113259","display_name":"Anticholinergic","level":2,"score":0.5850191712379456},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.5588628649711609},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4955343008041382},{"id":"https://openalex.org/C2780179036","wikidata":"https://www.wikidata.org/wiki/Q616181","display_name":"Serotonin syndrome","level":5,"score":0.4517003893852234},{"id":"https://openalex.org/C2780092697","wikidata":"https://www.wikidata.org/wiki/Q7455053","display_name":"Serotonin reuptake inhibitor","level":4,"score":0.4175412058830261},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2639612853527069},{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.22573083639144897},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1188250184059143},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000639","descriptor_name":"Amitriptyline","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000639","descriptor_name":"Amitriptyline","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000639","descriptor_name":"Amitriptyline","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011943","descriptor_name":"Receptors, Adrenergic, beta","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015057","descriptor_name":"1-Naphthylamine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015057","descriptor_name":"1-Naphthylamine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D015057","descriptor_name":"1-Naphthylamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015057","descriptor_name":"1-Naphthylamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017981","descriptor_name":"Receptors, Neurotransmitter","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020280","descriptor_name":"Sertraline","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:2842321","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2842321","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Clinical Trial"},{"id":"mag:89369262","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2842321","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2142514218","https://openalex.org/W1218447580","https://openalex.org/W2003059806","https://openalex.org/W1669455862","https://openalex.org/W2057710656","https://openalex.org/W2417155378","https://openalex.org/W2170086155","https://openalex.org/W7217715513","https://openalex.org/W2062678386","https://openalex.org/W4230863620"],"abstract_inverted_index":{"The":[0,64],"authors":[1],"review":[2],"preclinical":[3],"data;":[4,7],"clinical":[5],"pharmacology":[6],"and":[8,21,28,57,89,139,150],"efficacy":[9],"data":[10],"of":[11,40,47,60,67,121,130,132,153],"sertraline,":[12],"a":[13,26],"novel":[14],"serotonin":[15,30,55],"uptake":[16,31,56],"inhibitor.":[17],"Both":[18],"in":[19,22,103,111,113],"vitro":[20],"vivo,":[23],"sertraline":[24,52,68],"is":[25,58,69,126],"potent":[27],"specific":[29],"inhibitor":[32],"(possessing":[33],"up":[34,83],"to":[35,84,93,108,128],"10":[36],"times":[37],"the":[38,104,114,133,142,147],"activity":[39],"similar":[41,127],"agents).":[42],"Chronic":[43],"dosing":[44],"produces":[45],"down-regulation":[46],"beta-adrenergic":[48],"receptors.":[49],"In":[50],"man,":[51],"inhibits":[53],"platelet":[54],"devoid":[59],"obvious":[61,148],"cardiac":[62],"effects.":[63],"plasma":[65],"half-life":[66],"25":[70],"hours.":[71],"Studies":[72],"on":[73],"psychomotor":[74],"performance":[75],"show":[76],"little":[77],"or":[78],"no":[79],"effect":[80],"at":[81],"doses":[82],"100":[85],"mg,":[86],"whereas":[87],"200":[88,109],"400":[90],"mg":[91],"appear":[92],"possess":[94],"some":[95],"sedating":[96,151],"action.":[97],"Sertraline":[98],"exhibits":[99],"acute":[100],"antidepressant":[101],"effects":[102,152],"dose":[105,116],"range":[106,117],"50":[107],"mg/day;":[110],"addition,":[112],"same":[115,134],"it":[118,145],"prevents":[119],"recurrence":[120],"depression.":[122],"Its":[123],"side-effect":[124],"profile":[125],"that":[129],"drugs":[131],"class":[135],"(dry":[136],"mouth,":[137],"nausea,":[138],"diarrhea":[140],"being":[141],"most":[143],"prominent);":[144],"lacks":[146],"anticholinergic":[149],"amitriptyline.":[154]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W89369262","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
